Buchumschlag

Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthma

Long-term use of oral corticosteroids (OCS) is associated with a risk of adverse events and comorbidities. As such, a goal in assessing the efficacy of biologics in severe asthma is often to monitor reduction in OCS usage. Importantly, however, OCS dose reductions must be conducted without loss of d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Korn, Stephanie (VerfasserIn) , Howarth, Peter (VerfasserIn) , Smith, Steven G. (VerfasserIn) , Price, Robert G. (VerfasserIn) , Yancey, Steven W. (VerfasserIn) , Prazma, Charlene M. (VerfasserIn) , Bel, Elisabeth H. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 04 March 2022
In: Respiratory research
Year: 2022, Jahrgang: 23, Pages: 1-9
ISSN:1465-993X
DOI:10.1186/s12931-022-01959-1
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12931-022-01959-1
Volltext
Verfasserangaben:Stephanie Korn, Peter Howarth, Steven G. Smith, Robert G. Price, Steven W. Yancey, Charlene M. Prazma and Elisabeth H. Bel
Beschreibung
Zusammenfassung:Long-term use of oral corticosteroids (OCS) is associated with a risk of adverse events and comorbidities. As such, a goal in assessing the efficacy of biologics in severe asthma is often to monitor reduction in OCS usage. Importantly, however, OCS dose reductions must be conducted without loss of disease control.
Beschreibung:Gesehen am 05.04.2022
Beschreibung:Online Resource
ISSN:1465-993X
DOI:10.1186/s12931-022-01959-1

Ähnliche Einträge